HK Stock MarketDetailed Quotes

03320 CHINARES PHARMA

Watchlist
  • 5.300
  • -0.030-0.56%
Trading Nov 28 09:32 CST
33.30BMarket Cap8.04P/E (TTM)

CHINARES PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
4.71%128.6B
12.16%244.7B
-2.31%122.82B
-7.86%218.18B
9.81%125.72B
18.15%236.81B
28.08%114.49B
-1.97%200.42B
-12.30%89.39B
7.78%204.45B
Operating income
4.71%128.6B
12.16%244.7B
-2.31%122.82B
-7.86%218.18B
9.81%125.72B
18.15%236.81B
28.08%114.49B
-1.97%200.42B
-12.30%89.39B
7.78%204.45B
Cost of sales
-4.47%-107.66B
-11.81%-206.37B
2.67%-103.06B
8.37%-184.56B
-9.13%-105.88B
-19.80%-201.43B
-30.20%-97.02B
1.35%-168.13B
11.80%-74.52B
-10.13%-170.44B
Operating expenses
-4.47%-107.66B
-11.81%-206.37B
2.67%-103.06B
8.37%-184.56B
-9.13%-105.88B
-19.80%-201.43B
-30.20%-97.02B
1.35%-168.13B
11.80%-74.52B
-10.13%-170.44B
Gross profit
5.94%20.93B
14.04%38.34B
-0.36%19.76B
-4.98%33.62B
13.55%19.83B
9.56%35.38B
17.48%17.47B
-5.07%32.29B
-14.72%14.87B
-2.61%34.02B
Selling expenses
-1.49%-9.38B
-15.34%-18.91B
-1.80%-9.24B
6.48%-16.4B
-9.59%-9.08B
-9.37%-17.53B
-22.35%-8.28B
16.46%-16.03B
24.06%-6.77B
-4.62%-19.19B
Administrative expenses
-7.00%-3.04B
-13.44%-6.33B
2.98%-2.85B
10.55%-5.58B
-8.58%-2.93B
-12.07%-6.24B
-25.74%-2.7B
-6.93%-5.56B
8.28%-2.15B
-8.56%-5.2B
Operating interest expense
----
----
----
----
7.39%-1.36B
12.96%-2.74B
5.32%-1.47B
15.06%-3.15B
---1.55B
---3.71B
Special items of operating profit
-110.78%-857.54M
2.47%-1.84B
-542.26%-406.85M
-143.49%-1.88B
-540.76%-63.35M
-14.13%-773.81M
-28.30%14.37M
-215.67%-677.99M
-97.90%20.05M
15.80%586.15M
Operating profit
5.31%7.65B
15.37%11.26B
13.64%7.27B
20.58%9.76B
27.31%6.4B
17.85%8.09B
13.80%5.02B
5.69%6.87B
-38.10%4.41B
-47.17%6.5B
Financing income
59.52%372.15M
-18.51%587.69M
--233.3M
--721.18M
----
----
----
----
----
----
Financing cost
17.60%-1.18B
2.74%-2.39B
---1.43B
---2.45B
----
----
----
----
----
----
Share of profits of associates
-6.25%198.77M
25.51%417.11M
14.04%212.01M
5.98%332.34M
30.26%185.91M
51.60%313.6M
89.37%142.73M
47.31%206.85M
11.51%75.37M
2.37%140.42M
Earning before tax
12.14%7.05B
18.17%9.88B
-4.53%6.28B
-0.56%8.36B
27.39%6.58B
18.84%8.41B
15.07%5.17B
6.57%7.08B
-22.70%4.49B
-28.16%6.64B
Tax
-20.05%-1.51B
-23.61%-2.11B
11.23%-1.25B
3.29%-1.7B
-31.85%-1.41B
-0.52%-1.76B
-27.28%-1.07B
-13.63%-1.75B
25.16%-841.83M
4.25%-1.54B
After-tax profit from continuing operations
10.17%5.54B
16.78%7.78B
-2.69%5.03B
0.16%6.66B
26.23%5.17B
24.87%6.65B
12.25%4.09B
4.43%5.32B
-22.11%3.65B
-33.21%5.1B
Earning after tax
10.17%5.54B
16.78%7.78B
-2.69%5.03B
0.16%6.66B
26.23%5.17B
24.87%6.65B
12.25%4.09B
4.43%5.32B
-22.11%3.65B
-33.21%5.1B
Minority profit
25.06%2.94B
24.17%3.92B
9.53%2.35B
9.70%3.16B
29.40%2.14B
42.04%2.88B
54.71%1.66B
11.88%2.03B
-35.03%1.07B
-49.61%1.81B
Profit attributable to shareholders
-2.87%2.6B
10.11%3.85B
-11.35%2.68B
-7.13%3.5B
24.07%3.03B
14.31%3.77B
-5.40%2.44B
0.33%3.3B
-15.09%2.58B
-18.61%3.29B
Basic earnings per share
-4.65%0.41
8.93%0.61
-10.42%0.43
-6.67%0.56
23.08%0.48
15.38%0.6
-4.88%0.39
0.00%0.52
-14.58%0.41
-18.75%0.52
Diluted earnings per share
-4.65%0.41
8.93%0.61
-10.42%0.43
-6.67%0.56
23.08%0.48
15.38%0.6
-4.88%0.39
0.00%0.52
-14.58%0.41
-18.75%0.52
Currency Unit
CNY
CNY
CNY
CNY
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover 4.71%128.6B12.16%244.7B-2.31%122.82B-7.86%218.18B9.81%125.72B18.15%236.81B28.08%114.49B-1.97%200.42B-12.30%89.39B7.78%204.45B
Operating income 4.71%128.6B12.16%244.7B-2.31%122.82B-7.86%218.18B9.81%125.72B18.15%236.81B28.08%114.49B-1.97%200.42B-12.30%89.39B7.78%204.45B
Cost of sales -4.47%-107.66B-11.81%-206.37B2.67%-103.06B8.37%-184.56B-9.13%-105.88B-19.80%-201.43B-30.20%-97.02B1.35%-168.13B11.80%-74.52B-10.13%-170.44B
Operating expenses -4.47%-107.66B-11.81%-206.37B2.67%-103.06B8.37%-184.56B-9.13%-105.88B-19.80%-201.43B-30.20%-97.02B1.35%-168.13B11.80%-74.52B-10.13%-170.44B
Gross profit 5.94%20.93B14.04%38.34B-0.36%19.76B-4.98%33.62B13.55%19.83B9.56%35.38B17.48%17.47B-5.07%32.29B-14.72%14.87B-2.61%34.02B
Selling expenses -1.49%-9.38B-15.34%-18.91B-1.80%-9.24B6.48%-16.4B-9.59%-9.08B-9.37%-17.53B-22.35%-8.28B16.46%-16.03B24.06%-6.77B-4.62%-19.19B
Administrative expenses -7.00%-3.04B-13.44%-6.33B2.98%-2.85B10.55%-5.58B-8.58%-2.93B-12.07%-6.24B-25.74%-2.7B-6.93%-5.56B8.28%-2.15B-8.56%-5.2B
Operating interest expense ----------------7.39%-1.36B12.96%-2.74B5.32%-1.47B15.06%-3.15B---1.55B---3.71B
Special items of operating profit -110.78%-857.54M2.47%-1.84B-542.26%-406.85M-143.49%-1.88B-540.76%-63.35M-14.13%-773.81M-28.30%14.37M-215.67%-677.99M-97.90%20.05M15.80%586.15M
Operating profit 5.31%7.65B15.37%11.26B13.64%7.27B20.58%9.76B27.31%6.4B17.85%8.09B13.80%5.02B5.69%6.87B-38.10%4.41B-47.17%6.5B
Financing income 59.52%372.15M-18.51%587.69M--233.3M--721.18M------------------------
Financing cost 17.60%-1.18B2.74%-2.39B---1.43B---2.45B------------------------
Share of profits of associates -6.25%198.77M25.51%417.11M14.04%212.01M5.98%332.34M30.26%185.91M51.60%313.6M89.37%142.73M47.31%206.85M11.51%75.37M2.37%140.42M
Earning before tax 12.14%7.05B18.17%9.88B-4.53%6.28B-0.56%8.36B27.39%6.58B18.84%8.41B15.07%5.17B6.57%7.08B-22.70%4.49B-28.16%6.64B
Tax -20.05%-1.51B-23.61%-2.11B11.23%-1.25B3.29%-1.7B-31.85%-1.41B-0.52%-1.76B-27.28%-1.07B-13.63%-1.75B25.16%-841.83M4.25%-1.54B
After-tax profit from continuing operations 10.17%5.54B16.78%7.78B-2.69%5.03B0.16%6.66B26.23%5.17B24.87%6.65B12.25%4.09B4.43%5.32B-22.11%3.65B-33.21%5.1B
Earning after tax 10.17%5.54B16.78%7.78B-2.69%5.03B0.16%6.66B26.23%5.17B24.87%6.65B12.25%4.09B4.43%5.32B-22.11%3.65B-33.21%5.1B
Minority profit 25.06%2.94B24.17%3.92B9.53%2.35B9.70%3.16B29.40%2.14B42.04%2.88B54.71%1.66B11.88%2.03B-35.03%1.07B-49.61%1.81B
Profit attributable to shareholders -2.87%2.6B10.11%3.85B-11.35%2.68B-7.13%3.5B24.07%3.03B14.31%3.77B-5.40%2.44B0.33%3.3B-15.09%2.58B-18.61%3.29B
Basic earnings per share -4.65%0.418.93%0.61-10.42%0.43-6.67%0.5623.08%0.4815.38%0.6-4.88%0.390.00%0.52-14.58%0.41-18.75%0.52
Diluted earnings per share -4.65%0.418.93%0.61-10.42%0.43-6.67%0.5623.08%0.4815.38%0.6-4.88%0.390.00%0.52-14.58%0.41-18.75%0.52
Currency Unit CNYCNYCNYCNYHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data